Prevalence of SARS-CoV-2 antibodies in the Republic of Congo in mid-2021

OBJECTIVES: To estimate the seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies in the general population in the Republic of Congo. METHODS: In this cross-sectional study, conducted from June to July 2021, participants were recruited from the general population...

Descripción completa

Detalles Bibliográficos
Autores principales: Niama, Fabien R., Koukouikila-Koussounda, Félix, Mayengue, Pembé Issamou, Elguero, Eric, Ngoulou, Tarcisse Baloki, Levier, Victor, Makran, Jamal, Iroungou, Berthe A., Aghokeng, Avelin F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534787/
https://www.ncbi.nlm.nih.gov/pubmed/36217501
http://dx.doi.org/10.1016/j.ijregi.2022.09.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534787/
https://www.ncbi.nlm.nih.gov/pubmed/36217501
http://dx.doi.org/10.1016/j.ijregi.2022.09.012

Ejemplares similares